Sagimet Biosciences Inc.

NASDAQ: SGMT · Real-Time Price · USD
7.68
-0.99 (-11.42%)
At close: Aug 15, 2025, 3:59 PM
7.83
1.95%
After-hours: Aug 15, 2025, 07:47 PM EDT

Sagimet Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 2M n/a n/a
Cost of Revenue
n/a n/a 130K 134K
Gross Profit
n/a 2M -130K -134K
Operating Income
-54.45M -30.74M -31.05M -23.72M
Interest Income
n/a 2.86M 553K 26K
Pretax Income
-45.57M -27.88M -30.5M -24.44M
Net Income
-45.57M -27.88M -30.5M -24.44M
Selling & General & Admin
16.01M 12.96M 6.14M 4.38M
Research & Development
38.44M 19.78M 24.92M 19.34M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
54.45M 32.74M 31.05M 23.72M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
54.45M 32.74M 31.05M 23.72M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
31.35M 18.19M 22.17M 22.17M
Shares Outstanding (Diluted)
31.35M 18.19M 22.17M 22.17M
EPS (Basic)
-1.45 -1.53 -1.38 -1.1
EPS (Diluted)
-1.45 -1.53 -1.38 -1.1
EBITDA
-45.57M -30.74M -30.37M -24.31M
EBIT
-45.57M -30.74M -30.5M -24.44M
Depreciation & Amortization
n/a n/a 130K 134K